Canada markets close in 6 hours

Eliem Therapeutics, Inc. (ELYM)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.3050-0.1250 (-2.85%)
As of 10:00AM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 122.80M
Enterprise Value 16.35M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.14
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.41

Trading Information

Stock Price History

Beta (5Y Monthly) 0.51
52-Week Change 345.25%
S&P500 52-Week Change 321.61%
52 Week High 35.1900
52 Week Low 32.3400
50-Day Moving Average 32.8943
200-Day Moving Average 32.7397

Share Statistics

Avg Vol (3 month) 3682.64k
Avg Vol (10 day) 34.19M
Shares Outstanding 527.72M
Implied Shares Outstanding 627.72M
Float 84.79M
% Held by Insiders 126.12%
% Held by Institutions 167.24%
Shares Short (Mar 28, 2024) 413.22k
Short Ratio (Mar 28, 2024) 41.81
Short % of Float (Mar 28, 2024) 40.15%
Short % of Shares Outstanding (Mar 28, 2024) 40.05%
Shares Short (prior month Feb 29, 2024) 410.9k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-10.93%
Return on Equity (ttm)-29.72%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-35.12M
Diluted EPS (ttm)-1.3000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)106.8M
Total Cash Per Share (mrq)3.85
Total Debt (mrq)349k
Total Debt/Equity (mrq)0.32%
Current Ratio (mrq)38.92
Book Value Per Share (mrq)3.88

Cash Flow Statement

Operating Cash Flow (ttm)-20.6M
Levered Free Cash Flow (ttm)3.46M